Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-049222
Filing Date
2018-09-04
Accepted
2018-09-04 16:44:44
Documents
2
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4072
2 POA DOCUMENT poa.txt EX-24.4_807846 3670
  Complete submission text file 0001209191-18-049222.txt   9084
Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Altmeyer Mark (Reporting) CIK: 0001643074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 181052829

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations